Colcrys News and Research

RSS
Fewer patients take effective gout drug after steep price increase

Fewer patients take effective gout drug after steep price increase

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Actavis’ net revenue increases 40% to $2.66B in Q1 2014

Actavis’ net revenue increases 40% to $2.66B in Q1 2014

Actavis files ANDA with FDA to market  Colchicine Tablets USP

Actavis files ANDA with FDA to market Colchicine Tablets USP

Takeda enters definitive agreement to acquire URL Pharma

Takeda enters definitive agreement to acquire URL Pharma

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Colcrys safe for treating gout flares

Colcrys safe for treating gout flares

FDA takes action against unapproved single-ingredient oral colchicine

FDA takes action against unapproved single-ingredient oral colchicine

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Oramed reports Phase 2b non-FDA clinical trial results of ORMD-0801 oral insulin capsule

Oramed reports Phase 2b non-FDA clinical trial results of ORMD-0801 oral insulin capsule

Keryx Biopharmaceuticals commences Phase 3 registration program for Zerenex

Keryx Biopharmaceuticals commences Phase 3 registration program for Zerenex

Mount Sinai Medical Center's overall revenue growth for 2009 increased by 5%

Mount Sinai Medical Center's overall revenue growth for 2009 increased by 5%

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

Positive results from Ardea Biosciences' Phase 2b study of RDEA594 for hyperuricemia and gout

Positive results from Ardea Biosciences' Phase 2b study of RDEA594 for hyperuricemia and gout

Colcrys Patient Assistance Program introduced by URL Pharma

Colcrys Patient Assistance Program introduced by URL Pharma

URL Pharma's Colcrys approved by FDA for prevention of gout flares

URL Pharma's Colcrys approved by FDA for prevention of gout flares

Colchicine approved for acute gout, Mediterranean fever

Colchicine approved for acute gout, Mediterranean fever